This case introduces salauno, a for-profit company founded by two young entrepreneurs, Javier Okhuysen and Carlos Orellana, who wanted to eliminate needless blindness in Mexico. Untreated cataracts and complications from diabetes were the leading causes of blindness in Mexico as of 2017, and the entrepreneurs aimed to build an inclusive business focusing on low- and middle-income people who were either underserved or completely unserved by the existing Mexican health care market. salauno had experienced high growth since its beginning, but in early 2017, Okhuysen and Orellana faced a crucial test of their company's business model: they wanted to quickly scale the business to serve more patients and take advantage of improvements in cost efficiency, but could the company's financing sustain its ambitious growth plans? Would the existing financial base support salauno's future?